Login

Leon Benjamin, President and CEO of the Glimpse Group, was warmly welcomed at Nasdaq's listing ceremony. 00:10:00

Share On Facebook Share On Twitter

Lyron L Bentovim is Pres/CEO/Co-Founder at Glimpse Group Inc

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Reviving the Marilla Gold Plant: A Strategic Opportunity for Production Expansion
00:10:00
Challenges facing social entrepreneurs|Janade Du Plessis,General Partner,Launch Africa
00:10:00
Understanding Dividends: Building Wealth with Regular Income | Laurel Hardy, CEO, Bespoke Wealth Management.
00:10:00
Kevin Ford: Leading Calian Group Ltd. | Kevin Ford - CEO of Calian Group Ltd.
00:10:00
A companies that have redefined how teams build deploy and secure|Jesse Robbins,General Partner,Heavybit
00:10:00
Navigating Financial Uncertainty in a Potential Recession with Hyden Ross | Hyden Ross, Director, Pathway Financial Planners.
00:10:00
Capral Limited at the ASX Small and Mid-Cap Conference with Proactive | MR TONY DRAGICEVICH., CHIEF EXECUTIVE OFFICER AND MANAGING DIRECTOR, CAPRAL LTD
00:10:00
Unmasking the Pitfalls: How Media Impacts Investor Decisions
00:10:00
Mastering Markets: Toby Crabel on Counter-Trend Trading Strategies and Price Action | Toby Crabel – Commodities Trader, Crabel Capital Management
00:10:00
Yellowcake PLC CEO Andre Liebenberg Discusses Company Strategy and Uranium Market
00:10:00
Understanding the Consumer Price Index (CPI) and Its Impact | Mike Everritt, CIO, Taylor Financial.
00:10:00
Nodax: Danimer CEO Explores PHA's Potential for Single-Use Plastics | Stephen E. Croskrey - CEO of Danimer Scientific

© 2017 - Neuhu+